Back

Assesment of cardiac function during trastuzumab therapy in HER2 positive breast cancer patients

4 December 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: HIT Poster session 1 Systolic and Diastolic Function EACVI Premium Access EuroEcho 2019

About the speaker

Photo
Doctor Ivana Krstic

Institute for treatment and rehabilitation-Niska Banja, Niska Banja (Serbia)

27 More presentations in this session

Presentation thumbnail
Lunch time HIT Poster hosts - 12:45 - 13:45.
Presentation thumbnail
Echocardiographic prognosis score and stratification of the risk of major cardiovascular events after acute coronary syndrome.
Assistant Professor F. Menzou (Blida, DZ)
Abstract
Presentation thumbnail
Changes in left atrial function in patients one year follow up after radiofrequency catheter ablation for paroxysmal atrial fibrillation
Doctor D. Djikic (Belgrade, RS)
Presentation thumbnail
Postinfarction myocardial remodelling according to 2D ECHO data and genetic predictors: effect of genetic common variants in HSPB7 and MADD genes.
Mrs A. Kuular (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Effect of tofogliflozin on systolic and diastolic cardiac function in type 2 diabetic patients
Doctor K. Matsumura (Osaka, JP)
Abstract

Access the full session

Session thumbnail
HIT Poster session 1

The Event

Event poster

EuroEcho 2019

4 December - 7 December 2019
You may be interested in
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
LV diastolic function: how to deal with challenges
thumbnail
Congress Presentation
Evaluation of diastolic function and LV filling pressures: limitations of current guidelines 

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources